XIIDRA lifitegrast 50 mg/mL eye drops single-use ampoules Австралія - англійська - Department of Health (Therapeutic Goods Administration)

xiidra lifitegrast 50 mg/ml eye drops single-use ampoules

bausch & lomb australia pty ltd - lifitegrast, quantity: 50 mg/ml - eye drops, solution - excipient ingredients: sodium chloride; sodium hydroxide; sodium thiosulfate pentahydrate; water for injections; dibasic sodium phosphate - xiidra is indicated for the treatment of moderate to severe dry eye disease in adults for whom prior use of artificial tears has not been sufficient.

Dropodex 0.1% w/v eye drops, solution Мальта - англійська - Medicines Authority

dropodex 0.1% w/v eye drops, solution

rayner pharmaceuticals ltd 10 dominion way, worthing, west sussex, bn14 8aq,, united kingdom - dexamethasone phosphate - eye drops, solution - dexamethasone phosphate 1 mg/ml - ophthalmologicals

Ganfort 0.3mgml 5mgml eye drops 0.4ml unit dose Велика Британія - англійська - MHRA (Medicines & Healthcare Products Regulatory Agency)

ganfort 0.3mgml 5mgml eye drops 0.4ml unit dose

allergan ltd - timolol maleate; bimatoprost - eye drops - 5mg/1ml ; 300microgram/1ml

Trusopt 20mg/ml eye drops 0.2ml unit dose preservative free Велика Британія - англійська - MHRA (Medicines & Healthcare Products Regulatory Agency)

trusopt 20mg/ml eye drops 0.2ml unit dose preservative free

santen uk ltd - dorzolamide hydrochloride - eye drops - 20mg/1ml

Cosopt 20mg/ml / 5mg/ml eye drops 0.2ml unit dose preservative free Велика Британія - англійська - MHRA (Medicines & Healthcare Products Regulatory Agency)

cosopt 20mg/ml / 5mg/ml eye drops 0.2ml unit dose preservative free

santen uk ltd - dorzolamide hydrochloride; timolol maleate - eye drops - 20mg/1ml ; 5mg/1ml

Fixapost 50 micrograms/ml + 5 mg/ml eye drops, solution in single-dose container Ірландія - англійська - HPRA (Health Products Regulatory Authority)

fixapost 50 micrograms/ml + 5 mg/ml eye drops, solution in single-dose container

laboratoires thea - timolol; latanoprost - eye drops, solution in single-dose container - 50micrograms/ml +5 milligram(s)/millilitre - beta blocking agents1); timolol, combinations

Monopost Unidose 50 micrograms/ml eye drops, solution in single-dose container Ірландія - англійська - HPRA (Health Products Regulatory Authority)

monopost unidose 50 micrograms/ml eye drops, solution in single-dose container

laboratoires thea - latanoprost - eye drops, solution in single-dose container - 50 microgram(s)/millilitre - prostaglandin analogues1); latanoprost

TRUSOPT Preservative-Free 20 mg/ml eye drops, solution in single-dose container Ірландія - англійська - HPRA (Health Products Regulatory Authority)

trusopt preservative-free 20 mg/ml eye drops, solution in single-dose container

santen oy - dorzolamide - eye drops, solution in single-dose container - 20 milligram(s)/millilitre - carbonic anhydrase inhibitors; dorzolamide - antiglaucoma preparations and miotics, carbonic anhydrase inhibitors, dorzolamide - it l is indicated: as adjunctive therapy to beta-blockers; as monotherapy in patients unresponsive to beta-blockers or in whom beta-blockers are contraindicated; in the treatment of elevated intra-ocular pressure in: ocular hypertension; open-angle glaucoma; pseudoexfoliative glaucoma.

Elymbus 0.1 mg/g eye gel in single-dose container Ірландія - англійська - HPRA (Health Products Regulatory Authority)

elymbus 0.1 mg/g eye gel in single-dose container

laboratoires thea - bimatoprost - eye gel in single-dose container - bimatoprost

Combigan Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

combigan

abbvie limited - brimonidine tartrate 2 mg/ml;  ; timolol maleate 6.8 mg/ml equivalent to timolol base 5 mg/ml;   - eye drops, solution - 2mg/ml, 5mg/ml - active: brimonidine tartrate 2 mg/ml   timolol maleate 6.8 mg/ml equivalent to timolol base 5 mg/ml   excipient: benzalkonium chloride dibasic sodium phosphate heptahydrate hydrochloric acid monobasic sodium phosphate monohydrate purified water sodium hydroxide - combigan® eye drops are indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension not adequately responding to monotherapy.